Role of Cardiac AngioMR in Diagnosis of Cardiac and Vascular Anomalies in Adult Patients with Turner Syndrome
Condition(s) studied
Investigational drug(s) / intervention(s)
imaging: cardiac angioMR
Study summary
Considering the high prevalence of cardiovascular disease in Turner syndrome patients, noninvasive cardiac imaging is crucial for diagnosis and follow-up. From the review of the literature, it was evident that the imaging techniques used involved the evaluation of only the thoracic findings, in particular the heart and the thoracic aorta, while no data are currently available on the distal abdominal aorta or iliac arteries, since ultrasound and MRI are interrupted at the diaphragmatic level.
Eligibility
Primary outcome measure(s)
- Vascular and cardiac anomalies — 5 years
description of the main cardiovascular anomalies found by MRI at the thoracic and abdominal level anomalies in terms of supernumeray arteries and/or veins and measurement of length and diameters of main vascular tracts (e.g. ascending, descending aorta, aortic arch, renal arteries...) or vascular congenital abnormalities
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Unit of Endocrinology of Azienda Ospedaliera-Universitaria di Modena | Modena | Italy | Recruiting |
More Azienda Ospedaliero-Universitaria di Modena trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06178887 on ClinicalTrials.gov ↗ ← All trials in Italy